U.S. Taxpayers Fund Poor Drugs for Poor Nations

Resident Fellow Roger Bate
Resident Fellow
Roger Bate
New field research shows that a third of anti-malaria drugs collected in six African cities fail at least one quality test--and aid agencies continue to fund untested substandard drugs: poor medicine for poor people.

The World Health Organization suggests that one-fifth of the approximately one million children who die every year from malaria die because of substandard and poorly prescribed medicines.

In our sample of anti-malarial drugs sold in six African countries, we found 32 percent of those produced in Asia failed basic quality tests, as did 48 percent of those made in Africa, described in our paper published on May 7 in the U.S. Public Library of Science peer-reviewed medical journal PLoS One.

No U.S. legislator has asked why U.S. tax dollars are buying untested drugs, even though these drugs can endanger the people they were purchased to help.

Fake medicines are an increasing problem in richer nations, too. Fake Chinese heparin caused the deaths of at least 81 Americans; fake Viagra, cholesterol drugs and painkillers are also increasingly prevalent across the United States and Europe.

But while the U.S. Food and Drug Administration, the WHO, Interpol and European health and law enforcement agencies are doing their best to crack down on the major counterfeiters, taxpayer-funded aid agencies--including the Global Fund to Fights AIDS, Tuberculosis and Malaria--are still financing sales of untested and often poor, medicines to poor people.

Nirj Deva, Member of the European Parliament for the South East of England and the British Conservative Party's spokesman for International Development, asked the European Commission in March why it was funding "medicines in the developing world that would not in any instance be approved for use on EU citizens?"

Europe's Commissioner for Development and Humanitarian Aid, Louis Michel, provided a long-winded answer in which he admitted that "stimulating competition" to lower drug prices was the main reason--although he made no mention of the local tariffs that inflate those prices in many poor countries.

U.S. taxpayers support roughly a third of the Global Fund's budget--close to a billion dollars a year--but no U.S. legislator has asked why U.S. tax dollars are buying untested drugs, even though these drugs can endanger the people they were purchased to help, and may not lower prices.

After all, the German aid agency GTZ has reported that drugs produced locally in Ghana are often more expensive than imports from India, China, or Europe. Their effectiveness is even more debatable. The Global Fund only requires that the drugs come from facilities that can show good manufacturing practices (GMP), which means, in effect, a company that can produce aspirin is considered acceptable for producing more complex, and potentially harmful, anti-malaria drugs.

Roger Bate is a resident fellow at AEI.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate

What's new on AEI

Holder will regret his refusal to obey the Constitution
image 'Flood Wall Street' climate protesters take aim at their corporate allies
image 3 opportunities for better US-India defense ties
image Is Nicolás Maduro Latin America's new man at the United Nations?
AEI on Facebook
Events Calendar
  • 29
    MON
  • 30
    TUE
  • 01
    WED
  • 02
    THU
  • 03
    FRI
Thursday, October 02, 2014 | 9:00 a.m. – 10:30 a.m.
Campbell Brown talks teacher tenure

We welcome you to join us as Brown shares her perspective on the role of the courts in seeking educational justice and advocating for continued reform.

Friday, October 03, 2014 | 12:00 p.m. – 1:00 p.m.
Harnessing the power of markets to tackle global poverty: A conversation with Jacqueline Novogratz

AEI welcomes you to this Philanthropic Freedom Project event, in which Novogratz will describe her work investing in early-stage enterprises, what she has learned at the helm of Acumen, and the role entrepreneurship can play in the fight against global poverty.

No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.